-$33,000
Est. net congressional buying / selling (2 years). Updated Jun 9, 2026

Are Members of Congress Buying or Selling Clorox?

No members of Congress have reported trading Clorox (CLX) stock in the past 90 days. The history below covers the past two years.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the CLX AI Score. For corporate insider activity, see CLX insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading Clorox?

Member of CongressActivityTradesLast Trade
Jefferson Shreve Sold $33,000 1 Apr 11, 2025
Gilbert Cisneros Sold $16,000 3 May 15, 2026
Lisa McClain Bought $8,000 1 Jun 24, 2025

CLX Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Gilbert Cisneros May 15, 2026 Sell $1K – $15K
Gilbert Cisneros Dec 19, 2025 Buy $1K – $15K
Gilbert Cisneros Nov 12, 2025 Sell $1K – $15K
Lisa McClain Jun 24, 2025 Buy $1K – $15K
Jefferson Shreve Apr 11, 2025 Sell $15K – $50K

Frequently Asked Questions: Clorox Congress Trading

No members of Congress have reported buying or selling CLX stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Gilbert Cisneros sold Clorox (CLX) stock most recently, on May 15, 2026.

The estimated net value of congressional trades in Clorox over the past 2 years is negative, at -$33,000, meaning members of Congress have on balance sold more than they have bought.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.